Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Gitterman Wealth Management Selects Natixis for Tax Overlay Management in New SMART UMAs Focused on Sustainability
-
Verve Therapeutics Raises $63 million in Series A2 Financing to Advance Gene-Editing Therapies for Heart Disease
-
DirectBooks announces management team additions and the launch of its Industry Advisory Committee
-
Form SC 13G/A ERA GROUP INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A AERIE PHARMACEUTICALS Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Under Armour, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A PELOTON INTERACTIVE, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A PORTOLA PHARMACEUTICALS Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A SEACOR Marine Holdings Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A KENNAMETAL INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A MediWound Ltd. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
KKR Appoints Nicholas Hyde as Managing Director to Lead Client Partner Group in Australia & New Zealand
-
Statement of Ad Hoc Bondholder Group, May 22, 2020
-
Form 13F-HR WELLINGTON MANAGEMENT For: Mar 31
-
The Millicom Nomination Committee’s proposal for Board of Directors
-
The Millicom Nomination Committee’s proposal for Board of Directors
-
Form SC 13G/A PELOTON INTERACTIVE, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A BLUCORA, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G PTC THERAPEUTICS, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Triumph Bancorp, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A OMNICELL, Inc Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Affimed N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A KAR Auction Services, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Hyatt Hotels Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Hannon Armstrong Sustain Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A DYCOM INDUSTRIES INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Orion Engineered Carbons Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A STERLING BANCORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Great Ajax Corp. Closes $30 Million Private Placement
-
Wellington and Ontario Teachers’ Expand Strategic Relationship to Leverage Climate Science Research in the Pension Plan’s Investments
-
Diebold Nixdorf Shareholders Elect New Board Member, Re-Appoint Directors And Pass All Company Proposals During Annual Meeting
-
Holding(s) in Company
-
Statement of Ad Hoc Bondholder Group on Argentina Restructuring Terms
-
Holding(s) in Company
-
Form SC 13G Lantheus Holdings, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A REATA PHARMACEUTICALS Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A REDWOOD TRUST INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A GreenSky, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Forty Seven, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A MARRIOTT VACATIONS WORLD Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A PELOTON INTERACTIVE, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A HAEMONETICS CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A GLYCOMIMETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Zealand Pharma major shareholder announcement: Wellington Management Group LLP
-
John Hancock Hedged Equity & Income Fund Required Notice to Shareholders - Sources of Distribution Under Section 19(a)
-
Vostok Emerging Finance invests into Juspay, one of India’s leading payment companies.
-
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
-
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
-
Holding(s) in Company
-
Holding(s) in Company

